Jeffrey S. Heier Ocular Therapeutix, Inc (OCUL) insider trading activity

Jeffrey S. Heier is Chief Scientific Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 262,974 shares of OCUL, which is worth approximately $2.07 Million. The most recent transaction as insider was on May 23, 2025, when has been sold 3,024 shares (Common Stock) at a price of $7.18 per share, resulting in proceeds of $21,712. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

1.14% 3M change

338.78% 12M change

Total Value Held $2.07 Million

Jeffrey S. Heier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2025	SELL Open market or private sale	$21,712 $7.18 p/Share	3,024 Reduced 1.14%	262,974 Common Stock
Feb 24 2025	SELL Open market or private sale	$21,029 $6.87 p/Share	3,061 Reduced 1.14%	265,998 Common Stock
Nov 25 2024	SELL Open market or private sale	$26,561 $9.01 p/Share	2,948 Reduced 1.08%	269,059 Common Stock
Oct 02 2024	BUY Grant, award, or other acquisition	-	100,000 Added 26.88%	272,007 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	12,000 Added 16.68%	59,933 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	8,933 Added 15.71%	47,933 Common Stock
May 12 2022	BUY Open market or private purchase	$45,750 $3.05 p/Share	15,000 Added 27.78%	39,000 Common Stock

JSH

Jeffrey S. Heier

Chief Scientific Officer

Bedford,, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Value

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

Operation

Value

Type

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL

Account